US2015212080A1PendingUtilityA1
Saturation assay
Est. expiryNov 10, 2026(~0.3 yrs left)· nominal 20-yr term from priority
G01N 33/538G01N 33/54373G01N 33/537G01N 33/54313B01L 3/5023Y10S435/97B01L 2300/0825B01L 3/502753G01N 33/54366B01L 2200/0647B01L 2300/0681B01D 15/34Y10S435/971G01N 33/5302B01L 2200/0668B01L 2300/0816B01L 3/502761
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A modified form of saturation assay is provided that is based on the measurement of a free or unbound labelled reagent fraction (such that there is an increase in signal in the presence of analyte) and employs trapping zones to concentrate said unbound or free labelled faction to avoid loss of sensitivity. Preferably the assay is a membrane assay.
Claims
exact text as granted — not AI-modified1 . A kit for performing a saturation assay for detection of an analyte in a sample, the kit comprising:
a. a component for separating bound and unbound products of a competitive binding step; and b. a secondary trapping zone
2 . A kit according to claim 1 , further comprising a porous carrier.
3 . A kit according to claim 1 , wherein the component for separating bound and unbound products of a competitive binding step comprises a primary trapping zone.
4 . A kit according to claim 1 , further comprising a detectable moiety comprising at least one component selected from the group consisting of: microorganisms, cells, macromolecules, metal sol particles, beads, charcoals, kaolinites, bentonites, and latex beads.
5 . A kit according to claim 4 wherein the detectable moiety comprises colloidal gold.
6 . A kit according to claim 1 , wherein the saturation assay is an agglutination immunoassay and the primary trapping zone comprises a means for immobilizing an agglutinated fraction.
7 . A kit according to claim 4 , wherein the detectable moiety is agglutinable.
8 . A kit according to claim 6 , wherein the primary trapping zone comprises a capillary membrane of a pore size that excludes the agglutinated fraction.
9 . A kit according to claim 1 , wherein the component for separating bound and unbound products of a competitive binding step comprises a capillary membrane of a pore size that allows chromatographic separation of bound and unbound products on the basis of particle size.
10 . A kit according to claim 1 , wherein the secondary trapping zone comprises a component to immobilize and concentrate a free fraction of labelled analyte-binding reagent
11 . A kit according to claim 10 , wherein the secondary trapping zone comprises a capillary membrane of a pore size that excludes unagglutinated labelled reagent.
12 . A kit according to claim 11 , wherein the secondary trapping zone comprises an immobilized analyte-binding reagent or ligand or other cognate binding partner.
13 . A kit according to claim 1 , further comprising:
a. a hub to which two or more analyte-analogue moieties are bound; and b. two or more labelled analyte-binding reagents capable of binding said analyte-analogue moieties.
14 . A kit according to claim 1 , further comprising:
a. a hub to which two or more analyte-binding reagents are bound; and b. a signal particle comprising two or more analyte-analogue moieties capable of binding said analyte-binding reagents.
15 . A kit according to claim 1 , further comprising at least one components selected from the group consisting of: buffers, application means, instructions, charts, desiccants, control samples, dyes, batteries, and signal processing/display means.
16 . A kit according to any of claims 13 , wherein the pore size upstream of the primary trapping zone is sufficient to allow free movement of the hub, labelled reagent, sample and any agglutinate.
17 . A device for performing a saturation agglutination assay for detection of an analyte within a sample, the device comprising a carrier having a proximal end for receiving a sample, and a distal end toward which a sample may travel along the carrier, wherein the carrier comprises:
a. a primary trapping zone comprising means which exclude an agglutinated fraction; and b. a secondary trapping zone comprising a component which excludes a labelled reagent.
18 . A device according to claim 17 , wherein the carrier is porous.
19 . A device according to claim 18 wherein the primary and/or secondary trapping zones comprise a capillary membrane of a pore size that excludes an agglutinated fraction or labelled reagent, respectively.
20 . A kit comprising a device of claim 17 .Join the waitlist — get patent alerts
Track US2015212080A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.